Publication | Closed Access

Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01)

Bone DiseaseBreast OncologyBone HealthOncologyEarly Breast CancerPhase Iii TrialAdjuvant ChemotherapyBreast CancerMedicineRadiation OncologyOsteoporosisOrthopaedic SurgeryCancer Research